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Abstract
Background Medication is frequently thrown away after a patient’s discharge from hospital, with undesirable economic and 
environmental consequences. Because of the rising costs of healthcare, interventions to reduce medication wastage (and 
associated costs) are warranted. Using Patient’s Own Medication during hospitalisation might decrease medication wastage 
and associated costs. Objective To study the economic impact of patient’s own medication use on medication waste and 
hospital staff’s time spent during hospitalisation. Setting In seven Dutch hospitals, of which university, teaching, general, 
and specialised hospitals, eight different hospital wards, surgical and medical, were selected. Method In this prospective 
pre-post intervention study data on the economic value of medication waste and time spent by healthcare professionals 
were collected for a 2 months period each. The economic value of medication waste was defined as the value (€) of wasted 
medication per 100 patient days. For each ward, time spent on medication process activities was measured 10 times per 
staff member. The average time spent (in hours) on medication process steps (multiple activities) per staff member per 100 
patients and associated salary costs were calculated for both periods. Main outcome measure The primary outcome of the 
study was the total economic value (€) of wasted medication per 100 patient days. Results Implementation of Patient’s Own 
Medication decreased the economic value of wasted medication by 39.5% from €3983 to €2411 per 100 patient days. The 
mean time spent on the total medication process was reduced with 5.2 h per 100 patients (from 112.7 to 104.4 h per 100 
patients). We observed a shift in professional activities, as physicians and nurses spent less time on the medication process, 
whereas pharmacy technicians had a greater role in it. When time spent was expressed as salary; €1219 could be saved per 
100 patients. Conclusions This study showed that ‘Patient’s Own Medication’ implementation may have a positive economic 
impact, as the value of medication waste decreases, hospital staff devoted less time on the medication process, and staff 
deployment is more efficient.
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Impact on practice
• Patient’s Own Medication use is a valuable intervention 
for decreasing cost of medication waste, time spent by 
healthcare professionals, and costs of associated salary.
• To successfully implement Patient’s Own Medication 
use during hospitalisation, collaboration between hos-
pital staff is a precondition.
• Patient’s Own Medication implementation leads to a 
shift in professional activities in the current medication 
process by hospital staff.
Introduction
As healthcare costs are rising [1–3], interventions to 
reduce healthcare expenditures are warranted [4–8]. Medi-
cation represents a substantial and increasing proportion 
of healthcare budgets [1, 9, 10]. Unfortunately, a signifi-
cant part of medication remains unused and is disposed of. 
In the U.K. alone, medication waste is estimated to cost 
the National Health Service £300 million per annum [11]. 
Moreover, it has a negative impact on both the economy 
and the environment [12, 13]. Therefore, interventions to 
reduce medication waste are essential.
Medication waste occurs in both the ambulatory and 
acute care setting [8, 14–18]. While waste has been well 
studied in primary care [8, 14–16], little is known about 
the underlying reasons resulting in medication waste dur-
ing hospitalisation [17, 18]. Medication substitution upon 
hospital admission and discharge, is probably an important 
driver of medication waste and results into direct and indi-
rect unnecessary expenses. In most Western countries it is 
common practice that the hospital provides all inpatient 
medication, according to the hospital’s formulary. Pans 
et al. observed that during hospitalisation 31% of medica-
tion used at home is substituted by the hospital [19]. Fur-
thermore, when substitution is impossible, non-formulary 
medicines are purchased for individual patients. Both sub-
stitution and additional procurement of medication take 
a considerable amount of hospital staff’s time and there-
fore, results in additional costs. At discharge, however, 
substituted medicines are resubstituted to patient’s original 
medication by hospital staff. This in-hospital substitution 
policy takes significant time and leads to medication wast-
age as (opened) packages of medication are disposed of.
A promising intervention to reduce inpatient medica-
tion waste and medication-substitution related staff costs is 
the implementation of ‘Patient’s Own Medication’ (POM; 
also known as Patient’s Own Drug [POD]) use during 
hospitalisation [20]. Patients bring their own medication, 
provided by the community pharmacy, into the hospital 
when admitted. Consequently, substitution is no longer 
required. Therefore, POM use has the potential to improve 
the accuracy of admission orders and may decrease medi-
cation waste [21, 22]. Moreover, it may enhance oppor-
tunities for patient counselling and continuity of care 
between acute and primary care [23, 24]. Despite the pos-
sible advantages, POM use has not been implemented in 
routine health care. Concerns about the effects of POM use 
on medication safety and the uncertainty on economic ben-
efits may limit its implementation [25]. As a result, POM 
is not used in standard care in the Netherlands and no 
study has been performed to evaluate the economic impact 
of POM use. This study, therefore, aims to explore the 
impact of POM use on the (1) economic value of wasted 
medication, (2) quantity of wasted medication, and (3) 
time spent by hospital staff and associated salary costs.
Ethics approval
The ethical review board CMO Arnhem-Nijmegen, the Neth-
erlands, concluded that under Dutch law no ethical approval 
was required for this study (file number 2016-3088).
Methods
Design
A multicentre prospective intervention study with a pre-post 
design was conducted from August 2015 to June 2017. After 
a baseline 2-month pre-implementation period, the inter-
vention (POM use during hospitalisation) was implemented 
and subsequently followed by a 2-month evaluation of the 
implementation.
Study population
The study was conducted at eight different wards in seven 
Dutch hospitals, of which three university, two teaching, 
one general, and one specialised hospital. We included the 
departments of Cardiology, Internal medicine, Haematol-
ogy, Pulmonology, Medical Oncology, Orthopaedics, the 
combined wards Internal medicine/Gastroenterology/Geri-
atrics, and Gynaecology/Urology/Otorhinolaryngology. 
All patients admitted to the participating wards during the 
study were eligible for participation, if they already used 
medication before hospital admission or if medication was 
started during hospitalisation which was intended to be used 
at home. The use of individualised pre-packaged medication 
(either by an automated dispensing system or medication 
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organiser box), without the possibility of bringing the origi-
nal medication package to the hospital, was an exclusion 
criterion for participation in this study.
Pre‑intervention: standard care
In the Netherlands, the current hospital medication process 
generally starts with medication reconciliation at admission. 
Based on this, physicians electronically order this medica-
tion, typically taking the hospital’s formulary into account. 
When a medication is not on the hospital’s formulary, medi-
cation is substituted to a different brand and/or a different 
pharmacotherapeutic class. In case a medicine cannot be 
substituted, it is procured for that individual patient.
Most Dutch hospitals use a floor stock distribution sys-
tem. The stock comprises of the most frequently used medi-
cines for the department and is regularly restocked. When-
ever a medicine is not in stock, the medicine is dispensed 
from the pharmacy, where it is labelled and distributed to 
the requesting department. If the pharmacy does not have the 
medicine in stock, it places an order at a wholesaler or man-
ufacturer. Though differences among hospitals and depart-
ments exist, medication cart filling is mostly performed for 
the upcoming 24 h. During hospitalisation medication is 
administered by nurses, mostly by using Bar Code Medi-
cation Administration (BCMA). At discharge substituted 
medicines are resubstituted to the original medication by a 
physician. Newly initiated pharmacotherapy is prescribed 
by a physician as well. These prescriptions are filled by an 
outpatient pharmacy. All unused medication, including the 
specially procured medication, that has been dispensed dur-
ing admission, is disposed of at patient’s discharge. For an 
overview see Fig. 1.
Intervention: POM use during hospitalisation
In the intervention period patients were asked to bring their 
own medication in original packages to the hospital. In case 
of an acute hospitalisation, patient’s relatives were asked to 
bring these within 24 h. Medication reconciliation took place 
as in standard care. Thereafter, a physician electronically 
ordered patient’s home medication without any medication 
substitution. Patient’s own medication stock was checked 
by a nurse or pharmacy technician for completeness, shelf 
life, quality (by observation), and quantity. Thereafter, the 
medication was stored by patient name. Medication adminis-
tration was performed by nurses, as in standard care. Newly 
started medication that should be continued at home and 
POM that ran out of stock were provided by the pharmacy 
and stored by patient name as well. At discharge POM was 
gathered, including newly started therapies, and handed over 
to the patient. Discontinued medication was disposed of.
Data collection
In both study periods, data were collected during 2 months. 
The following ward characteristics were collected from the 
hospitals’ general databases and annual reports: number of 
inpatient beds, mean number of admitted patients per month, 
mean length of stay (LOS), mean age of the patient popula-
tion, and percentage acute admissions. All disposed medica-
tion was collected, identified, and quantified. The following 
medication characteristics were collected: name, dosage, 
quantity of individual units (e.g. number of tablets), unique 
identification code, Anatomical Therapeutic Code (ATC), 
and the price per unit.
Pre-intervention Post-intervention
Medication origins for a patient
Floor stock
Medication use for 1 day
Hospital’s stock
Medication use for 2-7 days
Individual purchases
Whole packages




Medication origins for a patient
Floor stock
Medication use for 1 day
Hospital’s stock





Fig. 1  Expected medication waste due to the medication process. The 
thicker the arrow the more medication is expected to be wasted or 
taken home due to the quantity of medication assigned to a patient. 
During the pre-implementation period, all assigned patient’s medica-
tion is disposed of at discharge. It is to be expected that after imple-
mentation of Patient’s Own Medication (POM) use, medication is not 
entirely disposed of at discharge as it is handed over to the patient
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Medication price per unit
To standardise medication prices, the price per unit was 
determined on the first of November 2017 using govern-
ment set pharmacy retail prices, as listed in the G-Stand-
ard [26]. The G-Standard is the Dutch medication data-
base, which is used by all parties in healthcare [26]. The 
G-Standard supports the different processes in healthcare, 
such as prescribing, dispensing, ordering, reimbursement, 
and clinical decision support [26]. This database lists the 
pharmacy retail price per unique medication identification 
code. When the unique medication identification code was 
not recognised by the database, for example because the 
product was no longer authorised, the retail price listed 
in de pharmacy system of the hospital where the product 
was disposed of was used as price per unit. Furthermore, 
if there was no retail price known, the net price per unit 
listed in the hospital pharmacy system was used. When 
both the retail and the net price were unknown, the study 
group manually searched for the retail price of the entire 
product group with the same generic prescription code and 
calculated the mean retail price per unit.
Time spent by hospital staff
Multiple groups of staff members play a role in the medi-
cation process, i.e. nurses, pharmacy technicians, physi-
cians, pharmacists, and general (pharmacy or logistic) 
employees. Medication process activities were identified 
during the pre- and post-implementation process using 
the ‘Value stream mapping’ method [27]. All activities 
were part of one of the following process steps: medi-
cation reconciliation, ordering, distribution, dispensing, 
administration, inform patient, and patient’s discharge. 
Activities performed within the medication process were 
measured at least ten times per ward per staff member by 
stopwatch timing. Activities could differ between wards 
and could change after POM implementation. If an activ-
ity did not change (same staff member, same activity) in 
the post-implementation period versus the standard care in 
the pre-implementation period, it was not measured again.
Outcomes
The primary outcome of the study was the economic value 
(€) of wasted medication per 100 patient days. The sec-
ondary outcomes were the mean quantity of medication 
waste per 100 patient days and the time spent by hospital 
staff on the medication process per 100 patients including 
associated salary costs.
Data analysis
For each ward, the economic value (€) of medication waste 
was calculated by dividing the total medication price per unit 
disposed of during the pre- and post-implementation period 
by the number of patient hospitalisation days (number of 
hospitalised patients on that ward times mean LOS) during 
the same period, and multiplied by 100 patients. In the same 
way the quantity of medication disposed of per 100 patient 
days was calculated as the total quantity of individual units 
disposed of. The mean time in hours (h) to perform activi-
ties within the medication process was calculated (if activi-
ties were measured ≥ 10 times) as the time per hospital staff 
member per medication process step per 100 patients. Only 
“medication distribution” was not defined as time spent to 
perform the activity per 100 patients, as an employee dis-
tributes medication once daily for the total ward and not per 
patient. In that situation the mean time spent per day was 
calculated and reported separately. Furthermore, time spent 
was expressed as economic value by calculating the mean 
maximum salary per hospital staff member related to the 
time spent on the process steps. Because salary scales differ 
between types of hospitals a mean maximum salary based 
on these scales was calculated. Analyses were performed in 
Microsoft Excel (version 2006) using descriptive statistics.
Results
In total, eight wards participated, of which six were medical 
and two were surgical wards. Ward and patient characteris-
tics are described in Table 1. All medical wards collected 
data on medication waste and all wards, with the exception 
of Ward B, collected data on time spent.
Value of wasted medication
The economic value of wasted medication per 100 patient 
days was €3983 and €2411 during the pre- and post-imple-
mentation period respectively (Fig. 2). There was a large 
variation in the value of wasted medication among the 
wards, both in the pre- and post-implementation period. Four 
wards showed a decrease in the value of wasted medica-
tion after implementation of POM, in one ward the opposite 
effect was observed, and one ward did not show a difference. 
After implementation of POM the total value of wasted med-
ication per 100 patient days decreased with 39.5% (€1572).
Quantity of wasted medication
The total quantity of medicines wasted was 1787 individual 
units per 100 patient days during the pre-implementation 
period and 2053 individual units per 100 patient days 
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during the post-implementation period: an increase of 14.9% 
(Fig. 3). Four wards showed a decrease in quantity of wasted 
medication per 100 patient days, of which three wards also 
showed a decrease in value of wasted medicines per 100 
patient days after POM use was implemented.
Time spent by hospital staff
A total of 2678 medication process activities were meas-
ured, of which 1729 pre- and 949 post-implementation. Of 
these 26 and 35 measurements were excluded respectively, 
as the activity was not measured ten times per staff mem-
ber, resulting in 2617 measurements used for analysis. The 
medication process took 112.7 h per 100 patients in the 
pre-implementation versus 104.4 h per 100 patients in the 
post-implementation period. Moreover, POM use resulted 
in a 5.2 h (4.6%) decrease per 100 patients in time spent by 
hospital staff. Furthermore, a shift in professional activities 
among staff members was observed. A reduction of time 
spent on medication process activities when POM use was 
implemented was accomplished for physicians (− 11.3 h/100 
patients) and nurses (− 16.2 h/100 patients). Pharmacy tech-
nicians had a more substantial role in the new medication 
process, which resulted in a increase in time spent of 22.2 h 
per 100 patients (Table 2). When time spent was translated 
to salary costs, the saved time and the shift in deployment 
resulted in net savings of €1219 per 100 patients.
The daily time spent on the distribution of medication 
by pharmacy technicians and general pharmacy or logistic 
employees was similar before (0.1 h) and after (0.1 h) imple-
mentation of POM use.
Table 1  Wards and patients characteristics during the pre- and post-implementation of Patient’s own medication (POM) use study periods
LOS, Length of stay; Pre-POM, pre-implementation of Patient’s own medication (POM) use study period; Post-POM, post-implementation of 
Patient’s own medication (POM) use study period; SD, standard deviation
a During the total study period















patient age (years; 
SD)
Post-POM Mean 
patient age (years; 
SD)
A Medical 32 4.5 69 113 136 70.3 (13.4) 70.4 (13.3)
B Medical 24 6.3 51 64 57 56.5 (16.9) 51.9 (17.3)
C Medical 50 6.1 59 30 30 59.9 (15.4) 63.8 (10.8)
D Medical 30 9.5 53 43 74 64.0 (21.0) 69.0 (17.7)
E Medical 28 6.8 56 116 109 60.1 (14.9) 58.3 (17.8)
F Medical 32 5.6 56 90 130 63.9 (14.8) 65.2 (15.8)
G Surgical 77 3.4 11 306 Unknown 56.2 (16.5) Unknown


















Fig. 2  Value (€) of wasted medication per 100 patient days during the 
pre- and post-implementation of Patient’s Own Medication (POM) 















Fig. 3  The quantity (n = individual units) of wasted medication per 
100 patient days during the pre- and post-implementation of Patient’s 
Own Medication (POM) use during hospitalisation on the participat-
ing medical wards
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Discussion
The implementation of POM use during hospitalisation 
showed a total potential saving of more than €1500 per 100 
patient days on medication waste costs. Nevertheless, an 
increase in the quantity of individual medication units dis-
posed of was shown. The POM process resulted in a decreased 
time spent by hospital staff of 5.2 h per 100 patients (4.6%) 
on the medication process when compared to standard care. 
A shift in responsibilities between staff members was shown, 
resulting in net savings of over €1200 per 100 patients.
This study was the first study that investigated the effect 
of implementing POM use on economic waste in hospital-
ised patients. POM use has recently been investigated in a 
Danish setting, but instead of focussing on waste Houlind 
et al. studied medication expenditures [28]. They concluded 
that implementing POM use did not lead to a significant dif-
ference between medication cost per patient when compared 
to the traditional medication system ($2.03 [95% confidence 
interval − 0.57 to 4.63] p = 0.131) [28]. Although medication 
cost was not subject to research in our study, it is expected 
that POM use will decrease hospitals’ medication expendi-
tures as less medicines should be ordered at the wholesaler 
because patients bring their own.
We observed considerable heterogeneity between wards 
in disposed of medication and related costs with the intro-
duction of POM. There are several possible reasons why not 
all wards showed a decrease in the value and quantity of dis-
posed of medication. Firstly, during the post-implementation 
period staff might not have adapted to the new medication 
process sufficiently. Consequently, staff might erroneously 
ordered outpatient medication packages for patients that 
were not eligible for POM use and forgot to endow home 
medication to the patient at discharge. These packages were 
all disposed of at discharge, and resulted in more medication 
waste during the post-implementation period. It is expected 
that if the medication process was performed according to 
protocol, less medication would have been disposed of. Sec-
ondly, it could be that more complex patients were admitted 
on the wards in the post-implementation period as study 
periods were randomly chosen. Treating complex patients 
may lead to additional changes in therapeutic therapy, result-
ing in starting and stopping medication more frequently and 
consequently increasing the quantity of medication being 
wasted.
To implement POM use during hospitalisation we antici-
pated that the current medication process required several 
adaptations to fit the new way of working. As a consequence, 
professional activities were assigned to other staff members. 
We observed, indeed, a shift in performer resulting in a net 
saving of time spent. Two medication process steps, order-
ing and medication administration, took hospital staff more 
time when POM use was implemented. This additional 
time spent may be explained by the fact that time measure-
ments took place directly after implementation. As staff may 
not have completely adopted the new medication process 
deployment yet; because of the shift in tasks, activities may 
have taken more time. It is to be expected that new tasks 
will be completed more rapidly when habituation occurs. 
Table 2  Mean time spent (in 
hours [h]) to perform an activity 
in the medication process per 
medication process step per 
staff member per 100 patients 
during the pre- and post-
implementation of Patient’s 
Own Medication (POM) use 
during hospitalisation
Pre-POM, pre-implementation of Patient’s own medication (POM) use study period; Post-POM, post-
implementation of Patient’s own medication (POM) use study period







Medication reconciliation Pharmacy technician 12.6 12.4 − 0.2
Physician 7.4 5.5 − 1.9
Nurse 6.2 3.8 − 2.4
Ordering Physician 6.0 6.0 0.0
Pharmacist 3.0 3.0 0.0
Pharmacy technician 0.5 17.4 + 16.9
Nurse 22.1 7.6 − 14.5
Dispense Pharmacy technician 7.4 7.4 0.0
Nurse 6.9 5.0 − 1.9
Medication administration Nurse 4.7 5.2 + 0.6
Inform patient Pharmacy technician 5.0 9.3 + 4.3
Physician 7.0 2.5 − 4.5
Patient’s discharge Pharmacy technician 10.2 11.4 + 1.2
Physician 10.7 5.8 − 4.8
Nurse 3.1 5.1 + 2.0
Total 112.7 107.4 − 5.2
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Consequently, the results of this study on time spent may be 
an overestimation.
The implementation of POM use is challenging due to 
needed adaptations in the medication process. It requires 
changes in: the role of patients and staff members, health 
care finance, hospital ICT systems, medication logistics, and 
hospital’s medication stock. Moreover, POM use raises some 
concerns as it may introduce (other types of) medication 
errors. For example the quality of the medication cannot 
be guaranteed, medication packages may be less recogniz-
able to nursing staff, and BCMA is not always possible. It 
is, therefore, important to continuously evaluate this new 
medication process and address the expected safety aspects 
of POM use [29].
Nevertheless, POM use initiates several opportunities as 
well. It has been suggested that POM use gives better oppor-
tunities for patient counselling and stimulates continuity of 
care [23, 24]. Moreover, several studies found that bringing 
POM into the hospital prevents medication errors at admis-
sion and after hospitalisation, and it improves the quality 
of medication used at home [21–23, 30]. Due to POM use 
during hospitalisation, patients may recognise their medica-
tion better which could have a positive effect on adherence 
at home, which is known to be a problem [31]. Lastly, POM 
use facilitates the opportunity of self-administration of med-
ication by hospitalised patients. Future studies, therefore, 
should focus on the effect of POM use during hospitalisation 
on medication safety and the applicability of self-adminis-
tration of POM.
A strength of this study is our study population which 
reflects the Dutch hospital patient population well. Those 
hospitals included, together account for a tenth of the total 
number of hospital admissions yearly in the Netherlands 
[32]. Moreover, the mean LOS and mean age of the popula-
tion are representative [32, 33].
This study has limitations. The participating wards did 
not include all patients who were able to participate in POM 
schemes. Moreover, we were unable to address the propor-
tion of admitted patients who participated in POM schemes 
on the included wards. The effects of POM use in this study, 
therefore, may have been underestimated as the total ward 
was measured. Another potential limitation was the rela-
tively short study period of 2 months for each phase. This 
may have limited the applicability of results found. Never-
theless, other studies on medication waste were conducted 
for shorter periods [30, 34]. In addition, by including differ-
ent ward types, hospitals, and seasons, the factors that influ-
enced medication waste varied. There were less time meas-
urements in the post-implementation period. This was due to 
a conscious choice in the set-up of the time measurements: 
activities that did not change were not measured again. This 
was chosen because the time measurements were very time 
consuming and were conducted by healthcare professionals 
on top of their normal care activities. This may have led to 
bias. Lastly, the post-implementation period started directly 
after the implementation. This may have resulted in unin-
tended medication waste and additional time spent on the 
medication process as a consequence of limited habituation. 
Therefore, the results of this study may underestimate the 
economic impact of and overestimate the time spent on POM 
use during hospitalisation.
In conclusion, POM use could reduce medication waste 
cost by more than €1500 per 100 patient days. We did not 
find a positive effect on the quantity of wasted medication. 
POM use took less of hospital staff time spent, namely: 
5.2 h per 100 patients; and in terms of salary more than 
€1200 could be saved per 100 patients. It is expected that 
our results underestimate the true effects when POM use is 
fully implemented. Furthermore, POM use may lead to a 
more efficient deployment of hospital staff.
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